3,4-dihydroxyphenylacetaldehyde has been researched along with Multiple System Atrophy Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goldstein, DS; Sharabi, Y | 1 |
Goldstein, DS; Holmes, C; Kopin, IJ; Mash, DC; Sharabi, Y; Sullivan, P | 1 |
1 review(s) available for 3,4-dihydroxyphenylacetaldehyde and Multiple System Atrophy Syndrome
Article | Year |
---|---|
The heart of PD: Lewy body diseases as neurocardiologic disorders.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Catecholamines; Dopamine; Heart; Humans; Lewy Bodies; Lewy Body Disease; Multiple System Atrophy; Myocardium; Neuroimaging; Neurons; Parkinson Disease; Sympathetic Nervous System | 2019 |
1 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and Multiple System Atrophy Syndrome
Article | Year |
---|---|
Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Aldehyde Dehydrogenase; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Frontal Lobe; Humans; Male; Methoxyhydroxyphenylglycol; Multiple System Atrophy; Neurons; Norepinephrine; Parkinson Disease | 2015 |